Bruker Corporation (BRKR) - News Archive

In a notable advancement for Bruker Corporation, the company has secured several multi-year contracts valued at over $27 million, specifically for its explosives and chemical trace detection solutions within the aviatio...

Bruker Corporation Pushes Innovation Boundaries with nVista 2P, Faces Financial Challenges CSIMarket.com Bruker Corporation (Nasdaq: BRKR), a leader in scientific instrumentation, has unveiled its pioneering nVista 2P m...

In a strategic move to enhance its diagnostic capabilities, Bruker Corporation (NASDAQ: BRKR) has announced a majority investment in RECIPE Chemicals + Instruments GmbH. Based in Munich, Germany, RECIPE is a recognized...

As the biotechnology landscape continues to evolve, Bruker Corporation finds itself at a crucial juncture. While the company gears up to showcase its groundbreaking advances at the upcoming AGBT 2025 conference, recent...

As the scientific landscape continuously evolves, technological advancements hold the key to competitive differentiation. At the forefront of this evolution in the materials science sector is Bruker Corporation, a notab...

Bruker Corporation (Nasdaq: BRKR), a leading innovator in scientific instrumentation, has recently announced a series of significant advancements that underscore its commitment to enhancing research capabilities in spat...

In a strategic move aimed at enhancing its competitive edge in the rapidly evolving field of life sciences, Bruker Corporation has announced the establishment of its new Bruker Spatial Biology division. Based in Billeri...

Bruker Corporation (Nasdaq: BRKR) has recently made an exciting announcement for its shareholders. The company s Board of Directors has approved the payment of a quarterly cash dividend of $0.05 per share on the Company...

The Intersection of Innovation and Collaboration: Bruker’s Strategic Moves in Drug Discovery and Diagnostics In the rapidly evolving landscape of biomedicine, few companies are as poised to make a significant impact as...

In a significant development related to ongoing patent litigation with 10x Genomics, Bruker Corporation has successfully posted a bond authorized by the Munich Higher Regional Court. This move has led to the immediate s...

Innovative Collaboration and Strategic Moves Propel Bruker and Cellens to the Forefront of Cancer Detection and Biophysical ResearchIn a groundbreaking partnership, Cellens, Inc., an early-stage cancer diagnostic compan...

Bruker Corporation, a leading provider of scientific instruments and solutions, recently unveiled its groundbreaking neofleX MALDI-TOF/TOF system at the 72nd ASMS meeting in Anaheim, California. This innovative system i...

Bruker Corporation, a leading provider of scientific instruments and solutions, recently announced its plans to host an Investor Webinar on May 17, 2024. The webinar aims to shed light on the company s recent acquisitio...

In a significant legal victory for NanoString Technologies Germany GmbH, the German Federal Patent Court has ruled in favor of the company by invalidating European Patent No. 2794928B1 (the 928 Patent) in Germany. This...